On the risk of secondary cancer from thymoma radiotherapy

医学 放射治疗 核医学 胸腺瘤 放射治疗计划 热释光剂量计 癌症 剂量计 放射科 外科 剂量学 内科学
作者
Wassim Jalbout,Rania Jbara,Chadia Rizk,Bassem Youssef
出处
期刊:Physics in Medicine and Biology [IOP Publishing]
卷期号:67 (15): 155015-155015 被引量:2
标识
DOI:10.1088/1361-6560/ac7c50
摘要

Abstract Objective. This study aims at quantifying the lifetime attributable risk of secondary fatal cancer (LARFAC) to patients receiving adjuvant radiotherapy treatment for thymoma, a neoplasm where cure rates and life expectancy are relatively high, patient age at presentation relatively low and indications for radiotherapy controversial depending on the disease stage. Approach. An anthropomorphic phantom was scanned, organs were contoured and a standard 6 MV 3DCRT treatment plan was produced for thymoma treatment. The phantom was loaded with thermoluminescent dosimeters (TLDs) and treated by linear accelerator per plan. The TLDs were subsequently read for out-of-field dose distribution while in-field dose distribution was obtained from the planning system. Sex and age-specific lifetime radiogenic cancer risk was calculated as the sum of in-field risk and out-of-field risk. The latter risk was estimated using hybrid ICRP 2007 103-BEIR VII tables of organ-specific risks based on the linear-no threshold (LNT) model and applicable at low doses, while the former using mathematical risk models applicable at high doses. Main results. The LARFAC associated with a prescribed dose of 50 Gy to target volume in 25 fractions was in the approximate range of 1%–3%. The risk was higher for young and female patients. The largest contributing organ to this risk were the lungs by far. Using the LNT model inappropriately to calculate risk at therapeutic doses (in-field) would overestimate the risk up to tenfold. Significance. The LARFAC to patient from thymoma radiotherapy was quantified taking into consideration the inapplicability of the LNT model at therapeutic doses. The risk is not negligible; the information may be relevant to patients and clinicians.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage应助科研通管家采纳,获得10
刚刚
刚刚
及禾应助科研通管家采纳,获得30
刚刚
刚刚
Jasper应助科研通管家采纳,获得10
刚刚
小杭76应助科研通管家采纳,获得10
刚刚
刚刚
胡三岁应助科研通管家采纳,获得10
1秒前
NIHAO发布了新的文献求助10
1秒前
我是老大应助科研通管家采纳,获得10
1秒前
SciGPT应助科研通管家采纳,获得10
1秒前
FashionBoy应助科研通管家采纳,获得10
1秒前
changping应助科研通管家采纳,获得10
1秒前
1秒前
1秒前
1秒前
1秒前
3秒前
tao发布了新的文献求助20
3秒前
momo完成签到 ,获得积分10
4秒前
5秒前
5秒前
5秒前
林炎完成签到,获得积分10
5秒前
zxd完成签到,获得积分10
7秒前
XCL发布了新的文献求助10
7秒前
yang发布了新的文献求助10
9秒前
JamesPei应助CYY采纳,获得10
10秒前
10秒前
10秒前
10秒前
11秒前
直率的破茧完成签到 ,获得积分10
11秒前
何雨航发布了新的文献求助10
11秒前
务实凡灵发布了新的文献求助20
11秒前
12秒前
12秒前
浮游应助blackbody采纳,获得10
13秒前
YY发布了新的文献求助10
13秒前
烟花应助NIHAO采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Petrucci's General Chemistry: Principles and Modern Applications, 12th edition 600
FUNDAMENTAL STUDY OF ADAPTIVE CONTROL SYSTEMS 500
微纳米加工技术及其应用 500
Nanoelectronics and Information Technology: Advanced Electronic Materials and Novel Devices 500
Performance optimization of advanced vapor compression systems working with low-GWP refrigerants using numerical and experimental methods 500
Constitutional and Administrative Law 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5299726
求助须知:如何正确求助?哪些是违规求助? 4447841
关于积分的说明 13843825
捐赠科研通 4333454
什么是DOI,文献DOI怎么找? 2378848
邀请新用户注册赠送积分活动 1374078
关于科研通互助平台的介绍 1339634